Authors
Loading...
This review reveals exosomes' potential as biomarkers and therapeutic platforms in metabolic diseases, highlighting challenges and approaches.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: